RenovoRx Inc - ESG Rating & Company Profile powered by AI
If you are employed by RenovoRx Inc and you would like to use your Sustainability rating, please contact us. Comprehensive ESG analysis of RenovoRx Inc are reached by signing up for free. The report of RenovoRx Inc is assembled by All Street Sevva using leading Cognitive Robots.
RenovoRx Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | RenovoRx Inc | 8.0 | High |
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does RenovoRx Inc have an accelerator or VC vehicle to help deliver innovation?
Does RenovoRx Inc disclose current and historical energy intensity?
Does RenovoRx Inc report the average age of the workforce?
Does RenovoRx Inc reference operational or capital allocation in relation to climate change?
Does RenovoRx Inc disclose its ethnicity pay gap?
Does RenovoRx Inc disclose cybersecurity risks?
Does RenovoRx Inc offer flexible work?
Does RenovoRx Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does RenovoRx Inc disclose the number of employees in R&D functions?
Does RenovoRx Inc conduct supply chain audits?
Does RenovoRx Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does RenovoRx Inc conduct 360 degree staff reviews?
Does RenovoRx Inc disclose the individual responsible for D&I?
Does RenovoRx Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does RenovoRx Inc disclose current and / or historical scope 2 emissions?
Does RenovoRx Inc disclose water use targets?
Does RenovoRx Inc have careers partnerships with academic institutions?
Did RenovoRx Inc have a product recall in the last two years?
Does RenovoRx Inc disclose incidents of discrimination?
Does RenovoRx Inc allow for Work Councils/Collective Agreements to be formed?
Has RenovoRx Inc issued a profit warning in the past 24 months?
Does RenovoRx Inc disclose parental leave metrics?
Does RenovoRx Inc disclose climate scenario or pathway analysis?
Does RenovoRx Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does RenovoRx Inc disclose the pay ratio of women to men?
Does RenovoRx Inc support suppliers with sustainability related research and development?
Does RenovoRx Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does RenovoRx Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is RenovoRx Inc involved in embryonic stem cell research?
Does RenovoRx Inc disclose GHG and Air Emissions intensity?
Does RenovoRx Inc disclose its waste policy?
Does RenovoRx Inc report according to TCFD requirements?
Does RenovoRx Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does RenovoRx Inc disclose energy use targets?
Does RenovoRx Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does RenovoRx Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for RenovoRx Inc
These potential risks are based on the size, segment and geographies of the company.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.